TScan Therapeutics, Inc.

NASDAQ:TCRX

4.75 (USD) • At close October 29, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -31.661-30.142-19.613-22.997-24.045-22.563-18.723-16.245-15.097-16.156-14.2-15.839-10.674-7.912-7.807-7.17-5.613-5.537
Depreciation & Amortization 1.1161.2541.281.2861.2961.4991.4841.2511.2071.1951.1421.0560.6610.4690.3960.3460.2660.222
Deferred Income Tax 00-4.701-0.2350000005.8960000000
Stock Based Compensation 2.3281.9841.51.3411.221.1471.2971.2461.0240.9840.7840.8850.5030.3440.150.1290.1250.111
Change In Working Capital 2.183-2.109-6.19828.399-0.711-3.884-0.284-3.298-0.501-6.147-2.1060.258-1.19-2.858-0.0910.90620.4670.075
Accounts Receivables 00031.926-31.9260000000000000
Change In Inventory 000-31.92631.9260000000000000
Change In Accounts Payables 0.396-0.41-0.641-0.2730.3670.4950.414-1.1180.4080.824-2.4620.8791.4310.1620.0560.5660.0360.469
Other Working Capital 1.787-1.699-5.55728.672-1.078-4.379-0.698-2.272-0.909-6.9710.356-0.621-2.621-3.02-0.1470.3420.431-0.394
Other Non Cash Items 3.9734.6483.9660.2230.2180.2140.216-3.3123.032.55-5.8962.1180.3941.120.0020.37520.0340.469
Operating Cash Flow -26.225-29.267-23.7668.017-22.022-23.587-16.01-17.002-13.367-20.124-14.38-13.64-10.7-9.957-7.35-5.78915.245-5.129
Investing Activities:
Investments In Property Plant And Equipment -0.862-0.705-0.469-1.419-0.42-0.838-1.377-0.424-1.893-0.531-2.211-0.853-3.918-2.959-1.385-1.343-0.323-1.187
Acquisitions Net 000000000000000000
Purchases Of Investments -48.354-8.779-17.618-59.99500000000000000
Sales Maturities Of Investments 15.545.64720000000000000000
Other Investing Activites -32.85436.8682.382-59.99500000000000000
Investing Cash Flow -33.71636.1631.913-61.414-0.42-0.838-1.377-0.424-1.893-0.531-2.211-0.853-3.918-2.959-1.385-1.343-0.323-1.187
Financing Activities:
Debt Repayment 000000-0.09400000000000
Common Stock Issued 161.5870.2580.019-0.252135.67600.19300.0310.08899.7389.6480.06299.8380000
Common Stock Repurchased 000.176-0.17600000000000000
Dividends Paid 000000000000000000
Other Financing Activities 161.5870.2580.019-0.076135.67600.00929.1290.0310.088-99.6190.608-0.68699.6260.040.0010.0260.221
Financing Cash Flow 161.5870.2580.019-0.252135.67600.10829.1290.0310.0880.1290.608-0.68699.6260.040.0010.0260.221
Other Information:
Effect Of Forex Changes On Cash 0052.63155.869-108.50000000000000
Net Change In Cash 101.6467.154-21.834-53.649113.234-24.425-17.27911.703-15.229-20.567-16.47176.115-15.30486.71-8.695-7.13114.948-6.095
Cash At End Of Period 242.159140.513133.359160.224213.873100.639125.064142.343130.64145.869166.436182.907106.792122.09635.38644.08151.21236.264